Literature DB >> 8393786

Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.

V Gorbulev1, H Büchner, A Akhundova, F Fahrenholz.   

Abstract

[Arg8]vasopressin and oxytocin are the two main members of the neurohypophysial hormone family found to be present in nearly all mammals. [Lys8]vasopressin ([Lys8]VP) has been identified as the antidiuretic hormone in pig and some marsupial families. The porcine-derived kidney epithelial cell line, LLC-PK1, expresses both [Lys8]VP receptors coupled to the activation of adenylate cyclase (V2 receptors) and oxytocin receptors. Here we report the molecular cloning of the V2 [Lys8]VP receptor and the oxytocin receptor from LLC-PK1 cells. The cloned V2 [Lys8]VP receptor differs from human and rat V2 [Arg8] receptors mainly in its N-terminal region, in residues located in the extracellular loops and in intracellular phosphorylation sites. When expressed in COS7 cells, the V2 [Lys8]VP receptor exhibits the relative order of ligand affinity [Lys8]VP = [Arg8]VP >> 1-deamino[D-Arg8]VP > or = oxytocin and adenylate-cyclase stimulation, expected for the porcine V2 [Lys8]VP receptor but different from V2 [Arg8]VP receptors. Adenylate-cyclase activation by [Lys8]VP was inhibited in COS7 cells by a V2 antagonist. The cloned oxytocin receptor exhibits in COS7 cells a ligand specificity typical of mammalian oxytocin receptors. mRNA-distribution analysis revealed a single 5.5-kb transcript in the uterus from pregnant guinea pig.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393786     DOI: 10.1111/j.1432-1033.1993.tb18000.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.

Authors:  H Hausmann; A Richters; H J Kreienkamp; W Meyerhof; H Mattes; K Lederis; H Zwiers; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.

Authors:  J Gutkowska; M Jankowski; C Lambert; S Mukaddam-Daher; H H Zingg; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

Authors:  J Peter; H Burbach; R A Adan; S J Lolait; F W van Leeuwen; E Mezey; M Palkovits; C Barberis
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

4.  Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor.

Authors:  D Firsov; B Mandon; A Morel; J Merot; S Le Maout; A C Bellanger; C de Rouffignac; J M Elalouf; J M Buhler
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

5.  Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

Authors:  C Serradeil-Le Gal; C Lacour; G Valette; G Garcia; L Foulon; G Galindo; L Bankir; B Pouzet; G Guillon; C Barberis; D Chicot; S Jard; P Vilain; C Garcia; E Marty; D Raufaste; G Brossard; D Nisato; J P Maffrand; G Le Fur
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Structure, characterization, and expression of the rat oxytocin receptor gene.

Authors:  F Rozen; C Russo; D Banville; H H Zingg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

7.  Inverse PCR-mediated cloning of the promoter for the rat vasopressin V2 receptor gene.

Authors:  B Mandon; A C Bellanger; J M Elalouf
Journal:  Pflugers Arch       Date:  1995-05       Impact factor: 3.657

Review 8.  Oxytocin: Narrative Expert Review of Current Perspectives on the Relationship with Other Neurotransmitters and the Impact on the Main Psychiatric Disorders.

Authors:  Tudor Florea; Matei Palimariciuc; Ana Caterina Cristofor; Irina Dobrin; Roxana Chiriță; Magdalena Bîrsan; Romeo Petru Dobrin; Manuela Pădurariu
Journal:  Medicina (Kaunas)       Date:  2022-07-11       Impact factor: 2.948

9.  Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

Authors:  B Chini; B Mouillac; Y Ala; M N Balestre; S Trumpp-Kallmeyer; J Hoflack; J Elands; M Hibert; M Manning; S Jard
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.